Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson’s Disease: A Perspective on Associated Therapeutic Interventions

Current pharmacotherapy of Parkinson’s disease (PD) is symptomatic and palliative, with levodopa/carbidopa therapy remaining the prime treatment, and nevertheless, being unable to modulate the progression of the neurodegeneration. No available treatment for PD can enhance the patient’s life-quality...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Mol Sci
Prif Awduron: Behl, Tapan, Kaur, Gagandeep, Bungau, Simona, Jhanji, Rishabh, Kumar, Arun, Mehta, Vineet, Zengin, Gokhan, Brata, Roxana, Hassan, Syed Shams ul, Fratila, Ovidiu
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2020
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7504186/
https://ncbi.nlm.nih.gov/pubmed/32872273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21176235
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg